People: Bristol-Myers Squibb Co (BMY.N)
18 Aug 2017
Dr. Thomas J. Lynch, Jr., M.D., Ph.D., is appointed as Executive Vice President, Chief Scientific Officer of the Company., effective March 16, 2017. He has served as the Chairman and Chief Executive Officer of Massachusetts General Physicians Organization since July 2015. He has also served as a member of the Board of Directors of Massachusetts General Hospital since 2015. From 2009 to 2015, he was the Director of Yale Cancer Center and the Richard and Jonathan Sackler Professor of Internal Medicine, Yale Cancer Center, Yale School of Medicine. He also served as the Physician-in-Chief of Smilow Cancer Hospital, Yale-New Haven. Prior to 2009, he served as Professor of Medicine at Harvard Medical School and Chief of Hematology/Oncology at Massachusetts General Hospital. Dr. Lynch is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.
|Total Annual Compensation, USD||122,500|
|Restricted Stock Awards, USD||170,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||30,000|
|Fiscal Year Total, USD||322,500|